Sequence information
Variant position: 150 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 521 The length of the canonical sequence.
Location on the sequence:
VLYLWALKILYPKTLFLLRG
N HECRHLTEYFTFKQECKIKY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VLYLWALKILYPKTLFLLRGN HECRHLTEYFTFKQECKIKY
Mouse VLYLWALKILYPKTLFLLRGN HECRHLTEYFTFKQECKIKY
Rat VLYLWALKILYPKTLFLLRGN HECRHLTEYFTFKQECKIKY
Bovine VLYLWALKILYPKTLFLLRGN HECRHLTEYFTFKQECKIKY
Slime mold IIYLYACKINYPNTFFLLRGN HECRHLTEYFTFKEECLHKY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 521
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform
Region
56 – 340
Catalytic
Active site
151 – 151
Proton donor
Metal binding
150 – 150
Zinc
Alternative sequence
87 – 318
Missing. In isoform 4.
Literature citations
Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.
Mizuguchi T.; Nakashima M.; Kato M.; Okamoto N.; Kurahashi H.; Ekhilevitch N.; Shiina M.; Nishimura G.; Shibata T.; Matsuo M.; Ikeda T.; Ogata K.; Tsuchida N.; Mitsuhashi S.; Miyatake S.; Takata A.; Miyake N.; Hata K.; Kaname T.; Matsubara Y.; Saitsu H.; Matsumoto N.;
Hum. Mol. Genet. 27:1421-1433(2018)
Cited for: VARIANTS ACCIID LEU-470 AND THR-473; INVOLVEMENT IN ACCIID; VARIANTS IECEE1 ARG-92; ILE-150 AND GLU-234;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.